768 related articles for article (PubMed ID: 8806788)
21. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
[TBL] [Abstract][Full Text] [Related]
22. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
23. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
24. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
[TBL] [Abstract][Full Text] [Related]
25. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
Moseley AB; Huston DP
J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
[TBL] [Abstract][Full Text] [Related]
27. Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation.
Kraft M; Filsinger S; Krämer KL; Kabelitz D; Hänsch GM; Schoels M
Immunology; 1995 Jul; 85(3):461-6. PubMed ID: 7558136
[TBL] [Abstract][Full Text] [Related]
28. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma.
Blank U; Boitel B; Mège D; Ermonval M; Acuto O
Eur J Immunol; 1993 Dec; 23(12):3057-65. PubMed ID: 8258318
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcal enterotoxin-mediated human T-T cell interactions.
Koning F; Rust C
J Immunol; 1992 Jul; 149(1):317-22. PubMed ID: 1535087
[TBL] [Abstract][Full Text] [Related]
30. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
31. V alpha domain modulates the multiple topologies of mouse T cell receptor V beta20/staphylococcal enterotoxins A and E complexes.
Bravo de Alba Y; Marche PN; Cazenave PA; Cloutier I; Sekaly RP; Thibodeau J
Eur J Immunol; 1997 Jan; 27(1):92-9. PubMed ID: 9022003
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens.
Rott O; Tontsch U; Fleischer B
J Immunol; 1993 Jan; 150(1):87-95. PubMed ID: 7678036
[TBL] [Abstract][Full Text] [Related]
33. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
34. One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation.
Nisini R; Fattorossi A; Ferlini C; D'Amelio R
Eur J Immunol; 1996 Apr; 26(4):797-803. PubMed ID: 8625970
[TBL] [Abstract][Full Text] [Related]
35. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
[TBL] [Abstract][Full Text] [Related]
36. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
37. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
Soares LR; Rivas A; Ruegg C; Engleman EG
Eur J Immunol; 1997 Jun; 27(6):1413-21. PubMed ID: 9209493
[TBL] [Abstract][Full Text] [Related]
38. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
39. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
Wen R; Blackman MA; Woodland DL
J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
[TBL] [Abstract][Full Text] [Related]
40. Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells.
Fuleihan R; Mourad W; Geha RS; Chatila T
J Immunol; 1991 Mar; 146(5):1661-6. PubMed ID: 1847171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]